Is thyroid hormone supplementation avoidable for patients with low‐risk papillary thyroid cancer after thyroid lobectomy? A two‐center observational study
Author:
Affiliation:
1. Department of Nuclear Medicine, West China Hospital Sichuan University Chengdu China
2. Department of Nuclear Medicine, Panzhihua Central Hospital Panzhihua University Panzhihua China
Publisher
Wiley
Subject
Endocrinology, Diabetes and Metabolism,Endocrinology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14580
Reference21 articles.
1. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2. Controversies in the Management of Low-Risk Differentiated Thyroid Cancer
3. Benefits and harms of hemithyroidectomy, total or near‐total thyroidectomy in 1‐4 cm differentiated thyroid cancer [published online ahead of print May 4, 2021];Xu Y;Clin Endocrinol (Oxf)
4. Association Between Implementation of the 2009 American Thyroid Association Guidelines and De-escalation of Treatment for Low-risk Papillary Thyroid Carcinoma
5. Surgeons’ Attitudes on Total Thyroidectomy vs Lobectomy for Management of Papillary Thyroid Microcarcinoma
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy;Surgery;2023-12
2. Lobo-isthmectomy in the management of differentiated thyroid cancer;Thyroid Research;2023-02-13
3. Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys;Diabetes Therapy;2022-11-03
4. Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022];Endokrynologia Polska;2022-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3